FDA Inspection
OneLegacy - Los AngelesOneLegacy - Los Angeles – FDA Inspection, Jun 8, 2009
Record Details
This FDA Inspection record concerns OneLegacy - Los Angeles, with an inspection on June 8, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneLegacy - Los Angeles
- Inspection Date
- June 8, 2009
- Product Type
- Biologics
View Company Profile
ID · d7a7d124-0fa1-4291-afbe-7096cc3941e1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 590134
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.320(a)Procedures re complaints
- 21 CFR 1271.160(b)(3)Actions taken and documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneLegacy - Los Angeles
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for OneLegacy - Los Angeles
- FDA Inspection 777350 - 2012-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.